Skip to main content
Liana Fraenkel, MD, Rheumatology, Pittsfield, MA

Liana Fraenkel MD MPH


Professor, Internal Medicine, Yale University School of Medicine

Join to View Full Profile
  • 777 North StSte 203Pittsfield, MA 01201

  • Phone+1 413-499-8551

  • Fax+1 413-442-9161

Dr. Fraenkel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Boston University Medical Center
    Boston University Medical CenterFellowship, Rheumatology, 1994 - 1998
  • McGill University Faculty of Medicine
    McGill University Faculty of MedicineClass of 1990

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1997 - 2027
  • CT State Medical License
    CT State Medical License 1998 - 2019
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Rheumatology
    American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

  • Fellow (FACR) American College of Rheumatology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Nonsteroidal Anti-Inflammatory Drugs vs Cognitive Behavioral Therapy for Arthritis Pain  
    Liana Fraenkel, Lisa Suter, Catherine Najem, JAMA Internal Medicine
  • A Qualitative Exploration of Triangulated Shared Decision Making in Rheumatoid Arthritis  
    Betty Hsiao, Liana Fraenkel, Arthritis Care & Research
  • Persistently Frequent Emergency Department Utilization Among Persons with Systemic Lupus Erythematosus  
    Lisa Gale Suter, Liana Fraenkel, Arthritis Care & Research
  • Join now to see all

Authored Content

  • Nonsteroidal Anti-Inflammatory Drugs vs Cognitive Behavioral Therapy for Arthritis PainJuly 2020

Press Mentions

  • All or Something: Experts Debate LDA vs. Remission as a Target in Rheumatoid Arthritis
    All or Something: Experts Debate LDA vs. Remission as a Target in Rheumatoid ArthritisApril 19th, 2022
  • New Medication Guidelines for Treating Rheumatoid Arthritis Released
    New Medication Guidelines for Treating Rheumatoid Arthritis ReleasedJuly 9th, 2021
  • New ACR Rheumatoid Arthritis Guideline: Emphasis on Methotrexate
    New ACR Rheumatoid Arthritis Guideline: Emphasis on MethotrexateJune 28th, 2021
  • Join now to see all

Grant Support

  • Improving Decision Making In Patients With Rheumatic DiseaseNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2011
  • Eliciting Patient Treatment Preferences For OsteoporosisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2004–2008

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: